Phase I study of HM12525A in healthy volunteers

Trial Profile

Phase I study of HM12525A in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs HM 12525A (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Sponsors Hanmi Pharmaceutical
  • Most Recent Events

    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 05 Jun 2015 New trial record
    • 03 Jun 2015 Results of this study will be presented at the American Diabetes Association's 75th Scientific Sessions, according to a Hanmi Pharmaceutical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top